Ages2Come
Menu
View all results →
Categories
⚡ Breaking
Crypto under weekend pressure, bitcoin slides below $80,000 on U.S. Middle East evacuations Why McDonalds, Microsoft and Google saying no to tokenized stocks isn't a dealbreaker Forced to pick, Grok’s AI model chooses Republicans. OpenAI’s picks Democrats.  These clever apps show off the iPhone Duo’s potential Argentina drops criminal probe into President Milei over crashed memecoin LIBRA I quit my marketing job to walk dogs for 4 months: It's 'one of the most valuable professional experiences I've ever had' Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer The Boox Palma 2 Pro finally got me to stop reading on my phone Wells Fargo, Cisco, Marvell among latest firms objecting to OKXICE's tokenized stock plan An ex-bookkeeper spent $375 to launch a sewing business: 'I hadn't felt so sure about something like that in a long time' Crypto under weekend pressure, bitcoin slides below $80,000 on U.S. Middle East evacuations Why McDonalds, Microsoft and Google saying no to tokenized stocks isn't a dealbreaker Forced to pick, Grok’s AI model chooses Republicans. OpenAI’s picks Democrats.  These clever apps show off the iPhone Duo’s potential Argentina drops criminal probe into President Milei over crashed memecoin LIBRA I quit my marketing job to walk dogs for 4 months: It's 'one of the most valuable professional experiences I've ever had' Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer The Boox Palma 2 Pro finally got me to stop reading on my phone Wells Fargo, Cisco, Marvell among latest firms objecting to OKXICE's tokenized stock plan An ex-bookkeeper spent $375 to launch a sewing business: 'I hadn't felt so sure about something like that in a long time'
Health / General

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

Source: cnbc October 24, 2026 · 07:30
Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer
Photo by Anna Tarazevich · Pexels
From the publisher
A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca. 
About the source

CNBC

The Consumer News and Business Channel (CNBC) is an American business news channel owned by Versant. The network broadcasts live business news and analysis programming during the morning, daytime business day, and early-evening hours, with the remaining hours filled by business-related documentaries and reality television programming, as well as occasional sports presentations from USA Sports. CNBC operates an accompanying financial news website, CNBC.com, which includes news articles, video and…

Wikipedia
Wikidata Q1023912
Wikidata ↗
Read original article ← Back to General

The original article opens on the publisher's website.

More from General

View topic →

Related to this story

Fact vs. fiction: Doctors share whether peptides are safe and effective
Oct 24 · 06:05
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent
Oct 24 · 04:30
U.S. birth rate drops to record low, but older women are having more babies
Oct 24 · 03:00
RFK Jr.’s vaccine injury clinic could damage NIH hospital, board warns
Oct 23 · 09:58

Explore

Health cnbc
Trending topics
#Here are the top AI agents that ca… #APOD: 2026 October 17 – 3D 67P #TechCrunch Founder Summit 2026: Ev… #Trump's AI executive order nears k… #See what 5 builders are making wit… #Global Oil Price Hits $117 a Barre…